Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Brain Injuries
Open-data reference.
24 US clinical trials · 9 currently recruiting
Active & Recent Trials
Screening Emotions in Adolescents at the Hospital for mTBI
University of California, Davis
NCT06370520
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
Emory University
NCT06932588
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
United States Naval Medical Center, San Diego
NCT06413173
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
University of Pittsburgh
NCT02592291
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
University of Alabama, Tuscaloo
NCT05965947
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
The University of Texas Medical Branch, Galveston
NCT06607523
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
Children's Hospital Medical Center, Cincinnati
NCT05250180
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
University of Texas Southwestern Medical Center
NCT04242602
Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Patients
University of Louisville
NCT06511804
Metacognition in Neurological Injury
University of Nebraska Lincoln
NCT03752697
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
BHR Pharma
NCT01143064
Validation Of TBI Detection System For Head Injured Patients
BrainScope Company
NCT02367300
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
BrainScope Company
NCT02367274
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
Oculogica
NCT02776462
Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC
Neuren Pharmaceuticals Limited
NCT01366820
Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults
Brigham and Women's Hospital
NCT05764824
Cortical Contributions to Motor Sequence Learning
Emory University
NCT04138953
The Use of Implementation Intentions to Increase the Appointment Attendance of OEF/OIF Veterans
VA Connecticut Healthcare System
NCT01649934
Hypothermia to Treat Severe Brain Injury
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00040339
Youth Soccer Header Study
University of Wisconsin, Madison
NCT04919707
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
The University of Texas Health Science Center, Houston
NCT00178646
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
University of Florida
NCT03112486
Impact of Custom Assistive and Adaptive Technology in Rehabilitation
Madonna Rehabilitation Hospital
NCT03567239
Magnesium Sulfate For Brain Injury
University of Washington
NCT00004730
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Brain Injuries Trial Landscape
ClinicalTrials.gov lists 24 US studies indexed under Brain Injuries, and 9 of those are currently open to recruitment — roughly 38% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Brain Injuries shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Brain Injuries is led by BrainScope Company with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 24 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Brain Injuries?
PlainTrial tracks 24 US clinical trials for Brain Injuries, of which 9 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Brain Injuries?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.